The power of Artificial Intelligence and Machine Learning looms over Medtech as a growing force that will bring change, good or bad. In this MedtechTalk Podcast, Michael D. Abramoff, MD, PhD, president and co-founder of IDx, tells how the start-up is using AI to better diagnose diabetic retinopathy. The company hopes to secure FDA approval for its IDx-DR system following the completion of clinical trials this summer.